About 289K results
Open links in new tab
Press Room - Sanofi US News
Sanofi lifts lid on data behind tolebrutinib’s mixed MS studies
Sanofi eyes approval after MS therapy slows disease progression …
Sanofi’s Multiple Sclerosis Drug Slows Disease’s Progression
Sanofi's tolebrutinib drug delays progressive MS by 31% in trial
Multiple sclerosis pill succeeds in key trial, Sanofi says - STAT
Sanofi presents new data from robust MS clinical pipeline …
Tolebrutinib clinical trial program update - Sanofi
Sanofi's Tolebrutinib Delays Disability Progression In Patients With ...
BTK Inhibitor Tolebrutinib Slows Disability Progression in Phase 3 ...